Supply Chain

The Institute for Supply Chain Management's manufacturing index jumped from 54.5 in December to 56.0 in January, according to The Wall Street Journal.

Here are five articles published by Becker's Hospital Review in the past week that highlight a device recall, one hospital's supply chain makeover and a viewpoint piece on the dangers of a deregulated Food and Drug Administration, among other topics.

The Institute for Clinical and Economic Review, a small nonprofit in Boston, developed a new value assessment framework to measure the value of drugs.

Minneapolis-based Medtronic is preparing to sell part or all of its medical supplies business, an unnamed source told Bloomberg.

U.S. Rep. Peter Welch, D-Vt., on Monday unveiled his plan to make prescription drugs more affordable for consumers, taxpayers and businesses providing health coverage to employees during an affordable medicine roundtable. 

Consumer confidence dropped in January after hitting a 15-year high in December, reports The Wall Street Journal.

Amazon will build an air cargo hub to accommodate its growing fleet of planes —another move in the Seattle-based retailer's transformation into a logistics provider, reports The Wall Street Journal.

Planning for supply chain interruptions should take place well before a disaster actually occurs, reports Manufacturing.net.

Minneapolis-based Medtronic earned clearance from the Food and Drug Administration for its CardioInsight Noninvasive 3-D Mapping System.

Japanese drugmaker Takeda Pharmaceuticals Co. on Wednesday said it would maintain its pricing model in the U.S., despite President Trump's demands to lower drug costs in the country, reports Reuters.